調查批次:CHT2017-01 | 檢體寄出日期:2017-02-06 | 報告回收截止日期:2017-02-13 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
Median of RIA Group |
- |
- |
||||||||||||||
Range of RIA Group |
- |
- |
||||||||||||||
Robust mean of RIA Group |
- ( n = 0 ) |
- ( n = 0 ) |
||||||||||||||
Robust SD of RIA Group |
- |
- |
||||||||||||||
CV of RIA Group |
- |
- |
||||||||||||||
Median of European RIA Labs |
15.8 ( n = 106 ) |
5.0 ( n = 106 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
14.8 - 20.7 |
4.4 - 6.5 |
||||||||||||||
RH01b,RH07b,RH14,RH15,CL009,CL010,CL012,CL014a,CL015,另予統計 | ||||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 4 |
3 |
9 |
13.8 |
-1.8 |
-11.5 |
-1.4 |
-0.4 |
-48 |
4.9 |
0.0 |
0.0 |
0.0 |
0.8 |
0 |
RH02c | RH02 | 4 |
3 |
1 |
12.6 |
-3.0 |
-19.2 |
-2.4 |
-1.2 |
-80 |
4.0 |
-0.9 |
-18.4 |
-2.3 |
-0.9 |
-77 |
RH06 | RH06 | 5 |
3 |
9 |
14.5 |
-1.1 |
-7.1 |
-0.9 |
0.0 |
-29 |
4.8 |
-0.1 |
-2.0 |
-0.3 |
0.6 |
-9 |
RH07a | RH07 | 4 |
3 |
2 |
14.1 |
-1.5 |
-9.6 |
-1.2 |
-0.2 |
-40 |
3.9 |
-1.0 |
-20.4 |
-2.6 |
-1.1 |
-85 |
RH12 | RH12 | 5 |
3 |
2 |
14.0 |
-1.6 |
-10.3 |
-1.3 |
-0.3 |
-43 |
4.0 |
-0.9 |
-18.4 |
-2.3 |
-0.9 |
-77 |
RH19 | RH19 | 7 |
3 |
2 |
16.0 |
0.4 |
2.6 |
0.3 |
0.9 |
11 |
5.1 |
0.2 |
4.1 |
0.5 |
1.1 |
17 |
RH20 | RH20 | 3 |
3 |
7 |
14.3 |
-1.3 |
-8.3 |
-1.0 |
-0.1 |
-35 |
4.4 |
-0.5 |
-10.2 |
-1.3 |
-0.2 |
-43 |
CL005 | CL005 | 7 |
3 |
9 |
15.4 |
-0.2 |
-1.3 |
-0.2 |
0.5 |
-5 |
4.9 |
0.0 |
0.0 |
0.0 |
0.8 |
0 |
CL006a | CL006 | 2 |
3 |
7 |
14.0 |
-1.6 |
-10.3 |
-1.3 |
-0.3 |
-43 |
4.4 |
-0.5 |
-10.2 |
-1.3 |
-0.2 |
-43 |
CL008 | CL008 | 7 |
3 |
2 |
16.9 |
1.3 |
8.3 |
1.0 |
1.5 |
35 |
4.7 |
-0.2 |
-4.1 |
-0.5 |
0.4 |
-17 |
CL011 | CL011 | 0 |
3 |
13 |
16.5 |
0.9 |
5.8 |
0.7 |
1.2 |
24 |
5.2 |
0.3 |
6.1 |
0.8 |
1.3 |
26 |
CL013b | CL013b | 1 |
3 |
1 |
12.2 |
-3.4 |
-21.8 |
-2.7 |
-1.4 |
-91 |
4.0 |
-0.9 |
-18.4 |
-2.3 |
-0.9 |
-77 |
Median of CLIA Group |
14.2 |
4.6 |
||||||||||||||
Range of CLIA Group |
12.2 - 16.9 |
3.9 - 5.2 |
||||||||||||||
Robust mean of CLIA Group |
14.5 ( n = 12 ) |
4.5 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
1.64 |
0.53 |
||||||||||||||
CV of CLIA Group |
11.3% |
11.8% |
||||||||||||||
Median of European CLIA Labs |
15.6 ( n = 1203 ) |
5.0 ( n = 1203 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
13.0 - 16.7 |
4.2 - 5.3 |
||||||||||||||
Median of All Labs |
14.2 |
4.6 |
||||||||||||||
Range of All Labs |
12.2 - 16.9 |
3.9 - 5.2 |
||||||||||||||
Robust mean of All Labs |
14.5 ( n = 12 ) |
4.5 ( n = 12 ) |
||||||||||||||
Robust SD of All Labs |
1.64 |
0.53 |
||||||||||||||
CV of All Labs |
11.3% |
11.8%
|
||||||||||||||
Median of All European Labs ( Xa ) |
15.6 |
4.9 |
||||||||||||||
uXa |
0.068 |
0.021 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
13.1 - 16.9 |
4.2 - 5.3 |
||||||||||||||
Mean of All European Labs |
15.4 ( n = 1430 ) |
4.8 ( n = 1430 ) |
||||||||||||||
SD of All European Labs |
2.06 |
0.64 |
||||||||||||||
CV of All European Labs |
13.4% |
13.2% |
||||||||||||||
SD for proficiency assessment ( σp ) |
1.248 |
0.392 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
- |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL013b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-02-15